Metaphase II (MII) oocytes obtained at different time points in the same in vitro fertilization cycle

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 11, 2012, Pages 1203-1205

  Cakmak, Hakan ^a   Fujimoto, Victor Y ^a   Zamah, A Musa ^a   Rosen, Mitchell P ^a   Tran, Nam D ^a   Cedars, Marcelle I ^a   Rinaudo, Paolo F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; MICROSOMAL AMINOPEPTIDASE; MUELLERIAN INHIBITING FACTOR; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ADULT; ANALGESIA; ARTICLE; ASCITES; CASE REPORT; CUMULUS CELL; EMBRYO DEVELOPMENT; ESTRADIOL BLOOD LEVEL; EVENING DOSAGE; FEMALE; FERTILIZATION IN VITRO; FLUID RESUSCITATION; FOLLICULAR ASPIRATION; GESTATIONAL AGE; HUMAN; HYPERKALEMIA; HYPONATREMIA; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MEIOSIS; MENSTRUAL IRREGULARITY; METAPHASE; NAUSEA; NIDATION; NULLIPARA; NUTRITIONAL INTOLERANCE; OOCYTE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PARACENTESIS; PREGNANCY; PRIORITY JOURNAL; PROPHASE; TRANSVAGINAL ECHOGRAPHY; VOMITING;

CHORIONIC GONADOTROPIN; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; METAPHASE; OOCYTE RETRIEVAL; OOCYTES; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878375623     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9852-5     Document Type: Article

References (16)

1. Andersen CY, Humaidan P, Ejdrup HB, Bungum L, Grondahl ML, Westergaard LG. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction. Hum Reprod. 2006;21(8):2126-30.
2. Bomsel-Helmreich O, Huyen LV, Durand-Gasselin I, Salat-Baroux J, Antoine JM. Timing of nuclear maturation and cumulus dissociation in human oocytes stimulated with clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin. Fertil Steril. 1987;48(4):586-95.
3. Chen SL, Ye DS, Chen X, Yang XH, Zheng HY, Tang Y, He YX, Guo W (2012) Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol. Hum Reprod
4. De Felici M, Klinger FG, Farini D, Scaldaferri ML, Iona S, Lobascio M. Establishment of oocyte population in the fetal ovary: primordial germ cell proliferation and oocyte programmed cell death. Reprod Biomed Online. 2005;10(2):182-91.
5. Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002;87(2):709-15.
6. Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab. 1983;57(4):792-6.
7. Honnma H, Hashiba Y, Asada Y, Endo T. Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports. Eur J Obstet Gynecol Reprod Biol. 2011;157(2):239-40.
8. Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod. 2009;24(10):2389-94.
9. Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes JM. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril. 1991;56(2):213-20.
10. McArdle CA, Franklin J, Green L, Hislop JN. Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors. J Endocrinol. 2002;173(1):1-11.
11. Popovic-Todorovic B, Loft A, Bredkjaeer HE, Bangsbøll S, Nielsen IK, Andersen AN. A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment. Hum Reprod. 2003;18(11):2275-82.
12. Rosen MP, Shen S, Dobson AT, Rinaudo PF, McCulloch CE, Cedars MI. A quantitative assessment of follicle size on oocyte developmental competence. Fertil Steril. 2008;90(3):684-90.
13. Seibel MM, Smith DM, Levesque L, Borten M, Taymor ML. The temporal relationship between the luteinizing hormone surge and human oocyte maturation. Am J Obstet Gynecol. 1982;142(5):568-72.
14. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Thomas S. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril. 2008;90(1):231-3.
15. Shapiro BS, Daneshmand ST, Restrepo H, Garner FC, Aguirre M, Hudson C. Efficacy of induced luteinizing hormone surge after «trigger» with gonadotropin-releasing hormone agonist. Fertil Steril. 2011;95(2):826-8.
16. Zelinski-Wooten MB, Lanzendorf SE, Wolf DP, Chandrasekher YA, Stouffer RL. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function. J Clin Endocrinol Metab. 1991;73(3):577-83.